Omnicell, Inc., headquartered in the United States, is a leading provider of medication management solutions and automation systems for healthcare facilities. Founded in 1992, the company has established itself as a key player in the healthcare technology industry, focusing on optimising pharmacy operations and enhancing patient safety. With a strong presence across North America and expanding operations in international markets, Omnicell offers a range of innovative products, including automated dispensing systems and medication adherence solutions. These offerings are designed to streamline workflows and reduce medication errors, setting Omnicell apart in a competitive landscape. Recognised for its commitment to improving healthcare efficiency, Omnicell has achieved significant milestones, including numerous awards for innovation and excellence in service delivery. As the demand for advanced healthcare solutions continues to grow, Omnicell remains at the forefront, dedicated to transforming medication management for providers and patients alike.
How does Omnicell's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Omnicell's score of 39 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Omnicell, headquartered in the US, reported total carbon emissions of approximately 5,245,000 kg CO2e, comprising 335,000 kg CO2e from Scope 1 and 4,910,000 kg CO2e from Scope 2 emissions. This reflects a decrease from 2023, where emissions were about 5,542,000 kg CO2e, with Scope 1 emissions at 392,000 kg CO2e and Scope 2 emissions at 5,149,000 kg CO2e. Over the past few years, Omnicell has shown a trend of reducing its carbon footprint, with 2022 emissions recorded at approximately 6,387,000 kg CO2e, including 475,000 kg CO2e from Scope 1 and 5,912,000 kg CO2e from Scope 2. The company has not disclosed any Scope 3 emissions data. Despite the positive trend in emissions reduction, Omnicell has not set specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The absence of formal reduction commitments suggests a need for further strategic planning in their climate action efforts. Overall, Omnicell's emissions data indicates a commitment to monitoring and managing its carbon footprint, although more robust targets and initiatives could enhance its climate strategy.
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 236,000 | 000,000 | 000,000 | 000,000 | 000,000 | 
| Scope 2 | 11,609,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 
| Scope 3 | - | - | - | - | - | 
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Omnicell has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
